SARS-CoV-2 Immunoglobulin M (IgM) Antibody Test (Serum/Plasma)
This test measures the presence of IgM antibodies in your blood, which may indicate an ongoing immune response to the SARS-CoV-2 virus (the virus responsible for COVID-19). IgM antibodies typically develop within days to weeks after infection and can help confirm past or recent exposure.
["IgM antibodies signal recent infection and help track immune response to COVID-19."]
Key facts at a glance
- LOINC
- 110252-4
- Short code
- SARS-CoV-2 IgG Msmt SerPl
- Synonyms
- SARS-CoV-2 IgG Msmt SerPl
- Category
- chemistry
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- CPT
- 82784
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
This test measures specific substances, cells, or markers in your body that can show how well certain organs and body systems are working. Your healthcare provider uses these measurements to check your overall health, look for early signs of illness, or monitor a condition you already have.
IgM antibodies are a type of antibody produced by your immune system in response to infection. When you are infected with SARS-CoV-2, your body starts producing IgM antibodies shortly after exposure. These antibodies are part of your body’s early immune defense and can appear within a few days to weeks after infection. This test detects these IgM antibodies in your serum or plasma to help determine if you have been recently infected with the virus.
Your provider may recommend this test during a routine checkup, to help find the cause of symptoms you are having, or to screen for certain health conditions. It can also be used to see how well a treatment is working or to follow an existing condition over time.
Doctors may order this test if you have symptoms of COVID-19, such as fever, cough, shortness of breath, or fatigue, and you suspect you may have been exposed to the virus. It can also be used in certain screening or monitoring situations, such as after potential exposure, during outbreaks, or in certain high-risk settings. This test is not typically used for initial diagnosis in most clinical settings due to its sensitivity to timing relative to infection.
In most cases, this test is done using a small sample of blood drawn from a vein in your arm, although some versions use a urine sample, a swab, or another type of specimen. Collecting the sample usually takes only a few minutes, and it is then sent to a laboratory for analysis.
A blood sample is drawn from a vein in your arm by a healthcare professional. The blood is then processed to separate the serum or plasma, which is tested for the presence of IgM antibodies using an immunoassay method. This method detects specific antibodies that bind to the virus’s proteins, confirming an immune response.
Results are usually described as normal or abnormal based on standard reference ranges. A normal result generally means no signs of concern were found, while an abnormal result does not automatically mean you are ill. Your provider will explain what your results mean and discuss any follow-up testing or treatment that may be needed.
A positive result means your blood contains IgM antibodies to SARS-CoV-2, suggesting you may have been recently infected. A negative result means no detectable IgM antibodies were found, which could mean you are not currently infected or that the test was taken too early for IgM to appear. Results should always be interpreted by a healthcare provider in the context of your symptoms, medical history, and other test results.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Clinical Significance
Short name
IgM Antibody to SARS-CoV-2
Frequently asked questions
IgM antibodies are useful for identifying recent infection and can help differentiate between past and current COVID-19 status. While IgM antibodies are typically detected earlier than IgG antibodies, they can decline over time. Together with IgG antibody tests, this information can provide a clearer picture of your immune response and past exposure to the virus. This test is particularly important in research, outbreak investigations, or situations where early detection of recent infection is critical.
Your healthcare provider may have recommended this test to assess whether you have recently been infected with the SARS-CoV-2 virus. This could be due to recent symptoms, exposure history, or specific clinical needs, such as monitoring in a healthcare setting or during an outbreak. It helps guide further testing or treatment decisions.
A positive IgM result suggests that you likely had an infection with SARS-CoV-2 within the last few weeks. This does not necessarily mean you are currently sick, but it does indicate your body is actively responding to the virus. Follow-up testing with IgG antibodies or other tests may be needed to confirm the timeline of your infection and overall immune response.
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy